Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601)

Shenzhen Kangtai Biological Products Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	190.63	1,196	1,018	3,550	882.69	505.22
Short-Term Investments	-	463.34	531.58	725.57	-	-
Trading Asset Securities	120.08	100.02	440.83	-	2,155	-
Cash & Short-Term Investments	310.71	1,759	1,990	4,275	3,038	505.22
Cash Growth	-70.41%	-11.61%	-53.45%	40.73%	501.29%	-20.39%
Accounts Receivable	2,879	2,788	2,293	1,858	1,613	1,051
Other Receivables	8.72	8.9	11.38	14.25	59.09	7.59
Receivables	2,888	2,797	2,305	1,872	1,672	1,058
Inventory	868.33	772.85	727.8	1,058	436.55	228.76
Other Current Assets	1,784	67.51	152.34	135.14	197.71	35.91
Total Current Assets	5,851	5,396	5,175	7,341	5,345	1,828
Property, Plant & Equipment	5,633	5,716	5,176	4,116	2,279	1,367
Long-Term Investments	-	311.68	302.38	105.64	101.71	-
Other Intangible Assets	445.75	433.45	357.98	346.04	294.36	311.54
Long-Term Deferred Tax Assets	643.57	630.32	708.32	558.6	702.05	271.78
Long-Term Deferred Charges	156.64	172.47	195.95	489.6	195.57	139.82
Other Long-Term Assets	1,785	2,425	1,871	1,192	667.18	33.84
Total Assets	14,516	15,085	13,786	14,149	9,585	3,952
Accounts Payable	789.03	882.48	434.13	708.2	167.36	116.57
Accrued Expenses	32.62	1,595	1,330	807.26	798.67	532.09
Short-Term Debt	155.68	60.04	170.07	777.53	11.32	1
Current Portion of Long-Term Debt	110.45	32.32	103.61	22.6	12.07	60
Current Income Taxes Payable	17.69	-	-	65.64	-	-
Current Unearned Revenue	23.83	28.76	31.23	94.51	14.95	28.73
Other Current Liabilities	1,489	152.69	270.96	142.39	751.57	131.79
Total Current Liabilities	2,619	2,751	2,340	2,618	1,756	870.18
Long-Term Debt	1,851	2,372	2,016	1,938	67.8	195.02
Long-Term Unearned Revenue	281.66	328.7	383.1	349.54	278.5	122.31
Long-Term Deferred Tax Liabilities	24.94	26.89	26.08	41.47	18.83	10.66
Other Long-Term Liabilities	30.15	64.51	36.33	35.13	-	-
Total Liabilities	4,806	5,544	4,801	4,982	2,121	1,198
Common Stock	1,117	1,117	1,120	687.09	684.93	645.22
Additional Paid-In Capital	5,410	5,369	5,490	5,357	5,265	1,118
Retained Earnings	2,672	2,544	1,884	2,612	1,555	1,077
Treasury Stock	-	-	-20	-0.55	-41.55	-85.84
Comprehensive Income & Other	510.96	511.1	511.14	511.3	-	-
Shareholders' Equity	9,709	9,542	8,985	9,167	7,463	2,754
Total Liabilities & Equity	14,516	15,085	13,786	14,149	9,585	3,952
Total Debt	2,117	2,465	2,289	2,738	91.19	256.02
Net Cash (Debt)	-1,806	-705.64	-299.34	1,537	2,947	249.2
Net Cash Growth	-	-	-	-47.84%	1082.44%	44.19%
Net Cash Per Share	-1.61	-0.63	-0.27	1.38	2.74	0.24
Filing Date Shares Outstanding	1,117	1,117	1,120	1,120	1,096	1,032
Total Common Shares Outstanding	1,117	1,117	1,120	1,099	1,096	1,032
Working Capital	3,232	2,645	2,835	4,723	3,589	958.02
Book Value Per Share	8.69	8.54	8.02	8.34	6.81	2.67
Tangible Book Value	9,264	9,108	8,627	8,821	7,169	2,443
Tangible Book Value Per Share	8.29	8.15	7.70	8.02	6.54	2.37
Buildings	-	2,718	1,037	939.37	859.63	743.25
Machinery	-	1,853	1,671	1,682	731.24	543.43
Construction In Progress	-	2,281	3,463	2,320	1,136	462.29

Source: S&P Capital IQ. Standard template. Financial Sources.